MAY 10, 2020 4:51 PM PDT

Antiviral Drug Treats Naso-Pharyngeal Cancer

WRITTEN BY: Nouran Amin

Scientists at Hong Kong Baptist University (HKBU) developed a novel anti-Epstein-Barr virus (EBV) drug that can shrink tumors caused by the EBV virus. It is the first known agent to successfully target the virus and disturb its latency in tumor cells in this way.

EBV infection spreads through close to close person contact and has infected more than 90% of the human population worldwide.

Learn more about the EBV virus and cancer:

Now, findings published in the journal Proceedings of the National Academy of Sciences found that potently reactivating the EBV from latency can be a form of nasopharyngeal carcinoma (NPC) therapeutic.  The drug works by binding and disrupting the vital EBV protein.

"This discovery lays a good foundation for the development of therapeutics for the treatment of EBV-associated diseases such as NPC," said Professor Gary Wong Ka-Leung.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 21, 2020
Health & Medicine
APR 21, 2020
How to Read COVID-19 News (Without Going Crazy)
  It can feel like COVID-19 news is consuming the country, and taking all the toilet paper and N95-masks with it. N ...
APR 20, 2020
Drug Discovery & Development
APR 20, 2020
First Successful Vaccine for Middle-East Respiratory Syndrome
Researchers have successfully completed the first-in-human clinical trial for a vaccine against MERS (Middle East Respir ...
APR 22, 2020
Drug Discovery & Development
APR 22, 2020
Using Colors To Track The Spread of Drug Particles
Forensic scientists from the National Institute of Standards and Technology (NIST) are relying on color to see the sprea ...
MAY 12, 2020
Immunology
MAY 12, 2020
Disabling Genes in Immune Cells Prevents Obesity
Obesity is a $1.7 trillion problem in the United States — a value almost 10% of the nation’s gross domestic ...
MAY 17, 2020
Cell & Molecular Biology
MAY 17, 2020
Potential Treatment for Brain and Spinal Cord Injury is IDed
Treatment options are limited for people that have suffered swelling-inducing injuries to their brain and spinal cord. N ...
MAY 21, 2020
Cancer
MAY 21, 2020
A New Player in the Regulation of Cancer's Microenvironment
Breast cancer is one of the most common cancers in the world.  Triple-negative breast cancer (TNBC) is a sub-type o ...
Loading Comments...